In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: Results from a European retrospective observational chart review

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Trew, Geoffrey H ^a   Brown, Adam P ^b   Gillard, Samantha ^b   Blackmore, Stuart ^c   Clewlow, Christine ^d   O'Donohoe, Paul ^e   Wasiak, Radoslaw ^e  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Decision Resources Group   (United Kingdom)

^c Formerly from Merck Serono   (United Kingdom)

^d Bedfont Cross   (United Kingdom)

^e UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; MERIONAL; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG; FOLLITROPIN; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; EUROPE; FEMALE; FERTILIZATION IN VITRO; HOSPITALIZATION; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; ECONOMICS; METHODOLOGY; MULTICENTER STUDY; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MENOTROPINS; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RECOMBINANT PROTEINS;

EID: 78049474566     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-137     Document Type: Article

References (21)

1. Ramlau-Hansen CH, Thulstrup AM, Nohr EA, Bonde JP, Sorensen TI, Olsen J. Subfecundity in overweight and obese couples. Hum Reprod 2007, 22(6):1634-1637. 10.1093/humrep/dem035, 17344224.
2. Jensen TK, Sobotka T, Hansen MA, Pedersen AT, Lutz W, Skakkebaek NE. Declining trends in conception rates in recent birth cohorts of native Danish women: a possible role of deteriorating male reproductive health. Int J Androl 2008, 31(2):81-92. 10.1111/j.1365-2605.2007.00827.x, 2440321, 17976178.
3. The ESHRE Capri Workshop Group Social determinants of human reproduction. Hum Reprod 2001, 16(7):1518-1526. 10.1093/humrep/16.7.1518, 11425841, The ESHRE Capri Workshop Group.
4. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007, 22(6):1506-1512. 10.1093/humrep/dem046, 17376819.
5. HFEA Fertility Facts and Figures 2007. 2009, HFEA., http://www.hfea.gov.uk/docs/adbcdfh.pdf
6. Westergaard LG, Bossuyt PM, van der Veen F, van Wely M. Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 2003, (1)., http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD003973/frame.html
7. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006, 21(12):3217-3227. 10.1093/humrep/del284, 16873892.
8. Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis. Reprod Biomed Online 2008, 16(1):81-88. 10.1016/S1472-6483(10)60559-7, 18252052.
9. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod 2008, 23(2):310-315. 10.1093/humrep/dem305, 18056719.
10. Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis. Gynecol Endocrinol 2009, 25(6):372-378. 10.1080/09513590802630120, 19340668.
11. Wechowski J, Connolly M, Schneider D, McEwan P, Kennedy R. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha. Fertil Steril 2009, 91(4):1067-1076. 10.1016/j.fertnstert.2008.01.034, 18339384.
12. Lloyd A, Kennedy R, Hutchinson J, Sawyer W. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction. Fertil Steril 2003, 80(5):1108-1113. 10.1016/S0015-0282(03)02185-X, 14607557.
13. NICE Clinical Guideline 11: Assessment and treatment for people with fertility problems Understanding NICE guidance - information for people with fertility problems, their partners, and the public. 2004, NICE., http://www.nice.org.uk/nicemedia/pdf/CG011publicinfoenglish.pdf
14. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Vanderpoel S. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 2009, 92(5):1520-1524. 10.1016/j.fertnstert.2009.09.009, 19828144.
15. Trew GH. Comparing highly purified hMG and rFSH in patients undergoing IVF. Hum Reprod 2007, 22(6):1797-1798. author reply 1798-1800, 10.1093/humrep/dem049, 17412753.
16. HFEA Multiple births and single embryo transfer review. 2010, HFEA., http://www.hfea.gov.uk/530.html
17. Balen A. Ovarian hyperstimulation syndrome (OHSS): a short report for the HFEA. 2008, , http://www.hfea.gov.uk/docs/OHSS_UPDATED_Report_from_Adam_Balen_2008.pdf
18. Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 1999, 14(2):354-358. 10.1093/humrep/14.2.354, 10099978.
19. MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993, 8(2):233-237.
20. Lobo FS, Wagner S, Gross CR, Schommer JC. Addressing the issue of channeling bias in observational studies with propensity scores analysis. Res Social Adm Pharm 2006, 2(1):143-151.
21. FIVNAT-CH Annual Report: Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction. 2009, FIVNAT-CH.